Osteopore Ltd (ASX: OSX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Osteopore Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$5.44 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
362.50 million
Earnings per share
-0.038
Dividend per share
N/A
Year To Date Return
130.77%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Osteopore Ltd (ASX: OSX)
Latest News
Healthcare Shares
Osteopore (ASX:OSX) share price rockets 24% on major new deal
Share Market News
Osteopore (ASX:OSX) share price moving higher on distribution deal
⏸️ Investing
Why I think these small cap ASX shares will perform in 2021
Share Market News
ASX medical share surges 30% on development news
Share Market News
2 breakthrough ASX healthcare shares
⏸️ Investing
3 innovative ASX shares to buy
Share Market News
Osteopore share price storms 270% higher on distribution deal
OSX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Osteopore Ltd
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
OSX Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 30 Jan 2026 | $0.02 | $0.00 | 0.00% | 45,744,946 | $0.02 | $0.02 | $0.02 |
| 29 Jan 2026 | $0.02 | $0.00 | 0.00% | 23,645,072 | $0.02 | $0.02 | $0.01 |
| 28 Jan 2026 | $0.02 | $0.00 | 0.00% | 24,724,361 | $0.02 | $0.02 | $0.02 |
| 27 Jan 2026 | $0.02 | $-0.01 | -50.00% | 40,858,260 | $0.02 | $0.02 | $0.02 |
| 23 Jan 2026 | $0.02 | $-0.01 | -38.46% | 30,727,005 | $0.03 | $0.03 | $0.02 |
| 22 Jan 2026 | $0.03 | $0.01 | 50.00% | 60,201,351 | $0.02 | $0.03 | $0.02 |
| 21 Jan 2026 | $0.02 | $0.01 | 76.92% | 62,771,583 | $0.01 | $0.02 | $0.01 |
| 20 Jan 2026 | $0.01 | $0.00 | 0.00% | 2,531,595 | $0.01 | $0.01 | $0.01 |
| 19 Jan 2026 | $0.01 | $0.00 | 0.00% | 12,647,984 | $0.01 | $0.01 | $0.01 |
| 16 Jan 2026 | $0.01 | $0.01 | 142.86% | 104,517,211 | $0.01 | $0.02 | $0.01 |
| 15 Jan 2026 | $0.01 | $0.00 | 0.00% | 3,058,306 | $0.01 | $0.01 | $0.01 |
| 14 Jan 2026 | $0.01 | $0.00 | 0.00% | 5,435,581 | $0.01 | $0.01 | $0.01 |
| 13 Jan 2026 | $0.01 | $0.00 | 0.00% | 3,694,459 | $0.01 | $0.01 | $0.01 |
| 12 Jan 2026 | $0.01 | $0.00 | 0.00% | 8,755,860 | $0.01 | $0.01 | $0.01 |
| 09 Jan 2026 | $0.01 | $0.00 | 0.00% | 20,307,919 | $0.01 | $0.01 | $0.01 |
| 08 Jan 2026 | $0.01 | $0.00 | 0.00% | 13,690,030 | $0.01 | $0.01 | $0.01 |
| 06 Jan 2026 | $0.01 | $0.00 | 0.00% | 1,200,000 | $0.01 | $0.01 | $0.01 |
| 05 Jan 2026 | $0.01 | $0.00 | 0.00% | 62,661 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 07 May 2025 | Mark Leong | Cancelled | 616,668 | $8,633 |
Cancellation of securities. 5,625,000 Performance rights
|
| 07 May 2025 | Mark Leong | Issued | 5,625,000 | $78,750 |
Issue of securities. 6,241,668 Performance rights
|
| 07 May 2025 | Swee Hin Teoh | Cancelled | 61,668 | $863 |
Cancellation of securities.
|
| 07 May 2025 | Swee Hin Teoh | Issued | 625,000 | $8,750 |
Issue of securities. 625,000 Rights
|
| 07 May 2025 | Daniel Ow | Cancelled | 61,668 | $863 |
Cancellation of securities.
|
| 07 May 2025 | Daniel Ow | Issued | 625,000 | $8,750 |
Issue of securities. 625000 Rights
|
| 07 May 2025 | Michael Keenan | Issued | 625,000 | $8,750 |
Issue of securities. 625,000 Rights
|
| 07 May 2025 | Yujing Lim | Issued | 526,754 | $7,374 |
Issue of securities.
|
| 07 May 2025 | Yujing Lim | Issued | 4,125,000 | $57,750 |
Issue of securities. 4,125,000 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Mark Kei Wei Leong | Executive ChairmanExecutive Director | Aug 2021 |
Mr Leong has corporate, management and directorship experience in a broad range of functions in a diverse range of industries having undertaken several C-suite roles (CEO, COO, & CFO) in several private as well as listed companies.
|
| Professor Swee Hin Teoh | Non-Executive Director | Jun 2019 |
Mr Teoh presently focuses on regenerative medicine research from tissue engineering bone and skin to biomimetic bioreactors to fish collagen, decellularized organs and others. He is a forerunner and educator in bioengineering and research scientist in translational regenerative medicine. His research focused on the study of mechanisms that promote cells proliferation and differentiation as a result of mechano-induction through load bearing scaffolds for tissue regeneration and
remodeling. |
| Hon Michael Keenan | Non-Executive Director | Jul 2023 |
Mr Keenan is a former Australian Government Cabinet Minister and brings expertise in public policy and corporate governance. He served as a Federal Member of Parliament from 2004 to 2019, holding senior ministry positions in the Abbott, Turnbull, and Morrison Governments between 2013 to 2019. His ministerial portfolios included Human Services, where he provided direction and oversight of Medicare, as well as Justice, Counterterrorism, and Digital Transformation. Notably, Mr. Keenan also serves on the Board of U Group and Co, as well as the Australian Strategic Policy Institute.
|
| Dr Yujing Lim | Chief Executive OfficerExecutive Director | Jul 2023 |
No profile reported.
|
| Mr Jack Rosagro | Company Secretary | May 2024 |
-
|
| Jack Rosagro | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 11,475,785 | 9.49% |
| BNP Paribas Nominees Pty Ltd <Uobkh R'Miers> | 7,493,264 | 6.20% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 6,123,942 | 5.07% |
| Mr Kelvin Chua Yong Wei | 3,480,919 | 2.88% |
| BNP Paribas Noms Pty Ltd | 3,464,764 | 2.87% |
| Mr Evan Philip Clucas & Ms Leanne Jane Weston <Kuranga Nursery Super A/C> | 3,273,864 | 2.71% |
| Mr Michael John Donnelly & Mrs Kylie Jayne Donnelly <M Donnelly Superfund A/C> | 3,119,207 | 2.58% |
| Mr Rommel Ainza Gan & Ms Shennie Chua Chua | 2,819,000 | 2.33% |
| Exosphere Investments Pty Ltd | 2,619,067 | 2.17% |
| Dr Russell Kay Hancock | 2,000,000 | 1.65% |
| Ms Fiona Elizabeth Greenhill | 1,923,245 | 1.59% |
| ABN Amro Clearing Sydney Nominees Pty Ltd <Custodian A/C> | 1,865,213 | 1.54% |
| Advance Opportunities Fund I | 1,567,398 | 1.30% |
| Mr Andrew Fraser Kerr | 1,540,000 | 1.27% |
| Terry Morris Pty Ltd <Morris Family Super A/C> | 1,275,000 | 1.05% |
| Koroneos Holdings Pty Ltd | 1,000,000 | 0.83% |
| Mr Mao Cai | 907,440 | 0.75% |
| Merrill Lynch (Australia) Nominees Pty Limited | 900,103 | 0.74% |
| Ms Kathleen Han | 894,504 | 0.75% |
| Ms Fiona Elizabeth Greenhill i | 835,767 | 0.69% |
